| The USA House of Representatives Committee on Energy and Commerce and its Subcommittee on Oversight and Investigations are probing the Vytorin-ENHANCE controversy by studying the “withholding of clinical trial data that may significantly affect the medical management of hypercholesterolemia, as well as the use of misleading statement in direct-to-consumer advertisements for prescription medicines.” Do you believe that this investigation is worthwhile? | ||
|---|---|---|
| # | Response Date | Other (please specify) |
| 1. | 4/22/2008 5:50:00 PM | Congressional panels are more about political gamesmanship than truth-finding. |
| 2. | 4/22/2008 10:03:00 PM | no |
| 3. | 4/22/2008 11:33:00 PM | And I think Merck will be cleared. |
| 4. | 4/23/2008 1:35:00 PM | This is congressional grandstanding. |
| 5. | 4/24/2008 1:31:00 AM | other things are more important |
| 6. | 4/24/2008 11:19:00 AM | congress needs to get out of this business |